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In 2002, Last Acts, a national campaign of the Robert Wood Johnson Foundation, issued a report 
assessing the states on access to end-of-life care and policies supporting its provision.  Quite 
striking for the hospice providers and other stakeholders of Maine, the state ranked second to last 
in hospice use among persons over age 65 in their last year of life.  Although anecdotal and 
unpublished data suggest that hospice use is on the rise in Maine, concerns about the low use rate 
remains a concern to those interested in end-of-life care in the State. 
 
In order to better understand the factors influencing the use of hospice in Maine, the Maine 
Hospice Council asked the Muskie School of Public Service to conduct a literature review 
synthesizing current knowledge on outcomes, use, cost, and barriers to end-of-life care.  This 
review provides a foundation for setting an overall research agenda for the Council. At the end of 
the report, we have outlined a set of questions for further research regarding end-of-life care in 
Maine.  
 
Growth in Use of Services 
Use of hospice services has increased significantly in recent years. Perhaps more striking than 
the increase in hospice use, is the shift in mix of people using hospice services. In 1992, 75% of 
all diagnoses for hospice care were cancer related. By 2005, cancer related diagnoses had 
dropped to 46% of all cases. The most prevalent non-cancer diagnoses in 2005 were heart 
disease (12%), dementia (9.8%) and lung disease (7.5%).1   
  
Barriers to Use of Hospice 
The literature identifies a number of barriers to the use of hospice services. These include: 
 
• Difficulty predicting life expectancy 
• Physician practices that do not support discussion of or referral to hospice 
• Lack of physician knowledge or exposure to end-of-life issues  
• Patient preferences for life-sustaining treatments 
• Refusal to acknowledge terminal condition by the patient or caregiver   
• Misunderstandings about the benefit 
 
Opportunities for Improving Use of Hospice Services 
A number of initiatives have been successful in improving access to and use of hospice care. 
Opportunities for improving access to hospice include:  
 
• Providing the right information early and often 
• Promoting collaborative efforts  among nursing homes and hospice providers 
• Improving the coordination and transition support provided with case management 
• Integrating curative and palliative care in new models of delivery 
 
Cost Effectiveness 
Studies of the cost effectiveness of hospice have shown mixed results. Most of the studies have 
shown savings to the Medicare program from the Medicare hospice benefit although the amount 
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of savings has varied according to the time frame over which savings are calculated and the 
diseases that have been studied.  One study found that Medicare costs in the last year of life  
were higher among hospice enrollees than non-enrollees but this varied by diagnosis and age.  
 
Most of the literature focuses on cost savings attributable to the Medicare hospice benefit. One 
actuarial cost study examined the impact of the Medicaid hospice benefit to the Medicaid 
program. This study estimated that without hospice, Medicaid would pay an additional $228 
million in order to continue end-of-life care in the hospital; an additional $41 million to pay for 
expensive pharmaceutical treatments; and an additional $13 million for the payment to nursing 
homes, due to the technical way in which nursing homes are paid when a person who is dually-
eligible for Medicaid and Medicare receives Medicare hospice in the nursing facility.2  
 
Very little research has been done on the cost savings to the Medicaid program of the Medicare 
hospice benefit. For people who are dually eligible for Medicaid and Medicare, the use of the 
Medicare hospice benefit could produce cost savings if the Medicare hospice benefit supplanted 
or replaced the services that a person would otherwise be receiving under the Medicaid program 
(e.g. home and community based services).  Further research in this area is needed. 
 
Quality Initiatives 
New initiatives are underway to bring quality assessment and improvement activities to the 
hospice industry.  Since 2000, the National Hospice and Palliative Care Organization has 
sponsored a National Data Set (NDS) to establish benchmarks for hospice practice throughout 
the country.3  Participation in the NDS allows hospices to compare themselves against other 
hospice providers performing similar activities.  Recommendations around quality have 
included:  
 
• The National Quality Forum endorses a framework for developing a comprehensive 
quality measurement and reporting system for palliative care and hospice services and 
endorses a set of preferred practices designed to improve palliative and hospice care.4   
 
• The Medicare Payment Advisory Commission has recommended that Medicare 
establish and collect quality measures for public reporting to encourage hospice quality 
improvement.5    
 
Further Research Questions 
The results of this literature review suggest a number of further questions for research. These 
include:  
• What is the rate of hospice use by setting (e.g., home, hospital, nursing home, patient 
home, and residential care) in Maine? How does this compare with national use rates? 
Who is using those services (e.g. people with dementia, people with cancer, etc)? 
• What is the relationship between supply of hospice providers and other providers and use 
of hospice in Maine? How does this vary by urban/rural areas? 
• What percent of people using home care or long term care in Maine have diagnoses and 
ADL levels that are potentially consistent with hospice use?  Are people who might be 
eligible for hospice being informed of/offered/using hospice? 
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• What are the factors that promote successful use of hospice in residential care and 
nursing facilities?  
• What is the quality of hospice services provided in Maine? 
• What is the impact of Medicare hospice use on Medicaid costs?  
• Are there ways to improve the coordination of end-of-life care and financing between 
Medicaid and Medicare?  
 
Summary 
Data is critical to understanding the cost, use and quality of hospice services in Maine. There are 
a number of data sources available that can help better inform policy and practice in Maine. This 
includes Medicare and Medicaid data, MDS nursing home data, MDS-RCA residential care data, 
and Mecare home care data. In addition, the hospice providers have data that is unique and could 
further inform policy and practice, These include data on supply, use of services by type of 
providers, and quality of services. Data, as transformed into information, is necessary to fully 
inform research, policy and practice on an ongoing basis.   
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2BI. Background   
 
Purpose 
In 2002, Last Acts, a national campaign of the Robert Wood Johnson Foundation, issued a report 
assessing the states on access to end-of-life care and policies supporting its provision.  Quite 
striking for the hospice providers and other stakeholders of Maine, the state ranked second to last 
in hospice use among persons over age 65 in their last year of life.  Only 9.1% of Mainers over 
65 used hospice in the last year of life, compared to the national average of 21.5%.6  This 
literature review seeks to understand the factors influencing low use of hospice in Maine by 
synthesizing current knowledge and research on outcomes, use, cost, and barriers to end-of-life 
care throughout the nation and the state.  From this synthesis, we will identify opportunities and 
approaches that can inform policy, professional practice, and public education efforts in Maine. 
We will also develop a set of research questions that can provide a foundation for setting an 
overall research and policy agenda for the Maine Hospice Council and others interested in end-
of-life care in Maine. 
 
Historical Context  
Credited with establishing the modern hospice movement, Dame Cicely Saunders sought to 
address dying patients’ isolation within hospitals, their need to reflect on their lives, and the safe 
use of opiates for pain control.  In 1967, Dr. Saunders opened the first modern hospice, St. 
Christopher’s Hospice of London, assembling professionals and volunteers to promote comfort 
and quality of remaining life among dying patients.  In 1969, On Death and Dying by Elizabeth 
Kubler-Ross argued for the provision of home care for the terminally ill and the involvement of 
patients in decisions affecting their care.  Inspired by these events, students of Yale University 
launched the first United States hospice in Connecticut in 1974.7, 8 ,9  Hospices that opened in 
these early years were based primarily within inpatient facilities and funded initially through 
grants and contributions.  The Medicare hospice benefit was enacted in 1982 emphasizing 
hospice care within the home.10  States were given the option of including hospice in their 
Medicaid programs in 1986.  
 
Hospice Services  
Today, hospice provides for the physical, emotional, and spiritual needs of patients nearing the 
end-of-life and their caregivers.  Emphasizing palliation rather than cure, patients’ physical needs 
are met through pain management and symptom control, while emotional and spiritual needs are 
addressed through counseling, pastoral care, and bereavement support of family and 
caregivers.11,12,13  The hospice interdisciplinary team includes providers such as physicians, 
nurses, social workers, chaplains, and volunteers.14  Though most hospice care is delivered 
within the patient’s or caregiver’s home, hospice care can also be delivered in nursing homes, 
hospitals, and within free-standing hospice agencies.  Hospice is primarily paid for by the 
Medicare program, but Medicaid, military, and commercial coverage also offer these benefits.   
 
Medicare Hospice Benefit Package  
To be eligible for the Medicare hospice benefit, beneficiaries must be certified as having six 
months or less to live by their physician. They must also be willing to forego other services 
related to curative treatment of their terminal illness. Beneficiaries remain eligible if they live 
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longer than six months as long as a hospice physician re-certifies that the patient has a terminal 
illness.11   
 
Patients’ out-of-pocket costs are minimal.  Medicare covers 95% of patients’ hospice costs and 
most hospices do not collect a 5% co-payment.15  Room and board costs for hospice care 
provided at home or in a nursing home or hospice residential facility are not covered by 
Medicare.  Patients also pay up to $5 for prescription drugs and other products for pain relief and 
symptom control and pay 5% of the Medicare payment amount for inpatient respite care.11 
 
Demonstrated Benefits  
Patients receiving hospice and their caregivers have reported better medical and social outcomes 
compared to other terminally ill patients not receiving hospice, particularly around pain and 
symptom management. Dying patients and their families have been shown to benefit from 
hospice by experiencing control of pain, fewer hospitalizations and invasive treatments and 
greater overall satisfaction.16  Results from the National Hospice Study (1985) indicated that 
patients served by home-based hospices received substantially more care at home and were 
hospitalized for fewer days in their last months than those in hospital based programs or those 
receiving conventional care. Patients in any type of hospice were less likely than those getting 
conventional care to receive diagnostic testing or intensive therapies.17   
 
In Utah, hospice was associated with improved pain relief and spiritual and emotional support.18  
Examining hospice care delivered by nursing homes in five states, hospice patients were more 
likely to have their pain detected and treated than those patients not in hospice.19  Interviews in 
four states with hospice staff and family members found hospice care associated with enhanced 
personal care and symptom management compared to patients not receiving hospice care.  
However, very few patients in either group reported receiving spiritual services and a small 
minority reported needing more spiritual services.20  A national mortality follow-back survey of 
family members also found unmet needs for emotional support among one in four terminally-ill 
patients in home-based hospice.21  
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3BII. Use and Supply of Hospice 
 
Growth in Use of Services 
Use of hospice services has increased significantly in recent years.  The number of hospice 
patients increased from 158,000 in 1985 to 1.2 million in 2005,1 while adult patients nearly 
tripled in number between 1991and 2000.22  Hospice use among Medicare decedents increased 
from 22% in 2000 to 31% in 2004.23  Hospice use varies greatly across the country. In 2002, 
hospice use rate for people over 65 was 28.6% but varied from a low of 8% in Alaska to a high 
of 45% in Colorado. Maine had the second lowest use rate of 14%. Rates in other states were: 
New Hampshire (24%); Vermont (19%); Massachusetts (23%); Florida (42%).24  
 
Considering patient characteristics, hospice use increased significantly throughout the 1990s for 
patients over age 85 and those with non-cancer diagnoses, Alzheimer’s disease, or dementia.22 In 
1992, 75% of all diagnoses were cancer related and by 2005, this had dropped to 46% of the 
diagnoses of people using hospice. The most prevalent non-cancer diagnoses in 2005 were heart 
disease (12%), dementia (9.8%) and lung disease (7.5%).1   
  
As of 2004, white Medicare decedents were the highest users of hospice, though hospice use has 
grown among beneficiaries of all racial groups.23 Among Medicare beneficiaries, hospice use is 
typically higher among managed care over fee-for-service enrollees.25  
 
Lower Use of Hospice in Rural Areas 
Patient use of hospice care is generally lower in rural areas compared to urban.  Rural areas not 
adjacent to an urban area had lowest hospice use at 15.2% of Medicare deaths.  The highest rate 
of use was found in urban areas at 22.2% of Medicare deaths, while rural areas adjacent to urban 
areas were at 17%.26  A 2003 study found the rate of hospice enrollment among rural patients 
was approximately 35% lower than urban patients for two types of cancer.  However, rural 
residents enrolled in hospice had a longer median enrollment than urban residents.27  Delivering 
hospice care in rural areas is complicated by travel distance to patients’ homes, low 
reimbursement amounts for rural providers, and the challenges of recruiting sufficient staff.28,29 
 
While nearly all (99%) metropolitan zip codes are served by a Medicare-certified hospice, fewer 
rural areas are served by a hospice.  Only 76% of zip codes in rural nonadjacent areas and 90% 
of zip codes in rural adjacent areas are served by a hospice.  In 2002, Maine had a relatively high 
proportion (95.6%) of its Medicare population living in areas served by hospice.30 As of 2000, 
about 60% of Maine’s population lived in non-metropolitan areas.31  Since hospice use is lower 
in rural areas, Maine’s rural nature may factor into low hospice use.   
 
Racial Differences in Hospice Use Rates not Apparent 
An analysis of hospice data across all payers found that significant racial differences in the use of 
hospice apparent in the early 1990s had nearly disappeared by 2000.22  Among the Medicare 
population, white decedents remain the highest users of hospice, but hospice growth has 
occurred among beneficiaries of all racial groups.23  Black patients do differ from white patients 
in that they were more likely to be younger, have Medicaid as their payment source, and were 
more likely to have HIV/AIDS than white hospice patients.22   
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Increase in For-profit and Larger Hospices  
Like use, the availability of hospice care has also increased substantially, particularly during the 
1990s.  The number of Medicare-certified hospice providers grew by 82% between 1992 and 
1998, from 1,208 providers to 2,196.32  Growth in the hospice industry was particularly strong 
among for-profits and large hospice programs as well as among providers in rural areas.  
Between 1992 and 1999, rural providers increased by 116% while the number of urban providers 
increased by 64%.  However, even among these growing sectors, the majority of hospices were 
small (with fewer than 100 patients each year), non-profit, and located in urban areas.32   
 
Growth in hospice availability has continued in more recent years, albeit more slowly than 
during the 1990s.  The number of hospice agencies participating in Medicare rose 26% between 
2001 and 2005, attributable to a 57% increase in freestanding hospice providers.23  As of 2006, 
46% of hospice providers were for-profit compared to 31% in 2001.25  In a survey conducted in 
Maine, 96.5% of Maine physicians reported that hospice services were available in their 
community in 2005.33   
 
Home is Primary Setting of Hospice Use 
Most hospice care is provided in the home by voluntary nonprofit agencies and by hospice 
agencies affiliated with some other type of provider.  In 2000, most hospice discharges had 
received hospice care at home (61.2%), while slightly more than one-third (34.9%) had received 
care at a health facility.  Only a small proportion (3.5%) received care from an assisted living or 
residential care facility.  Most hospice discharges were served by voluntary nonprofits (80%), 
while 15.8% were proprietary and 4.5% were owned by government or another source. About 
two-thirds of discharges were from hospice providers affiliated or owned by a chain, hospital, 
nursing home, or HMO.34  
 
Length of Stay  
Hospice length of stay (LOS) and timing of hospice care prior to death have been sources of 
concern to the industry and patient advocates since Medicare implemented its benefit in 1982.13  
Various data sources show a trend toward many short stays and few long stays prior to the year 
2000.  From 1992 to 1998, average LOS declined by 20% (from 74 to 59 days), while median 
LOS declined 27% (from 26 to 19 days).32  Among Medicare beneficiaries, one-fifth (20%) 
entered hospice one week before their death while 6% entered more than 6 months before 
death.27  Between 1991 and 2000, the percent of patients with hospice stays of 7 days or fewer 
increased significantly by 14%.  The percent of hospice patients enrolled for six months or more 
also significantly declined during that time.35 Overall, 58.9% of discharges had a LOS less than 
30 days.34   More recent data indicates a modest reversal in short LOS.  In 2005, average LOS 
was 59 days, while median LOS was 26 days.1  As of 2001, Maine mirrored that median with a 
LOS of 27.4 days.6 
 
LOS varies by demographic characteristics, diagnosis, and geography.  Among Medicare 
beneficiaries, shorter hospice stays were predicted by demographic characteristics such as being 
male, white, married, and having fee-for-service insurance.27  Patients with Alzheimer’s disease 
had a mean stay of 44.9 days while persons with cerebrovascular disease had a much shorter 
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length of stay of 6.1 days, with much longer stays for patients with heart disease (61.2 days). 
Patients with cancer had an average length of stay of 43.3 days.34  
 
Average LOS varied by state from a low of 41 days in South Dakota to a high of 122 days in 
Mississippi in 2004.25  The average LOS for Maine was 59-68 days during 2004.23   
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4BIII. Barriers to Hospice Enrollment  
 
Difficulty Predicting Life Expectancy 
Repeated consistently throughout the literature, hospice referral is hampered by the difficulty in 
accurately predicting a patients’ death to within six months, the standard eligibility criteria for 
most third party payers.36  Prognosis is especially difficult with non-cancer diagnosis because the 
course of disease is often uneven.  Patients with cancer typically experience a long period of 
good function, with a few weeks or months of rapid decline leading to death.  Other conditions 
such as organ system failure are characterized by a slow decline in physical capacity marked by 
serious exacerbations and sudden death.  Dementia and frailty are marked by decreasing function 
over the long-term, requiring years of personal care.32,37,38 
 
In a national sample of internists, physicians disagreed about the length of time prior to death 
that indicates a terminal condition.  Physicians who defined terminal as meaning a longer length 
of time until death (24 weeks) were more likely to refer to hospice than physicians that defined 
terminal as a shorter length of time (four weeks).  Physicians who felt that terminality could not 
be defined by time were 52% less likely to favor hospice use.39 
 
Physician Practice Patterns and Knowledge 
Though the vast majority of physicians report positive opinions of hospice,36,39, 40,41significant 
variations in the actual practice of hospice referral are apparent.  Among internal medicine 
physicians within a non-profit HMO, 37% identified the difficulty in predicting a patients’ death 
to within six months, the most commonly identified barrier to hospice referral.36  It appears that 
some physicians may not be aware that Medicare hospice eligibility can be recertified 
indefinitely once the initial six months has past.  Other barriers included: lack of time to discuss 
dying and hospice care; rapid demise of patient; family did not need additional support; and 
physician did not think to make referral.36  Some physicians may delay hospice referral out of 
concern that they may lose control of the patient’s care, unaware that they may continue to care 
for a patient referred to hospice.32,40  Also, physicians may not be fully aware of the minimal cost 
of hospice care to patient and family under Medicare.40 
 
Hospice leaders perceived medical specialists, surgeons, younger physicians, and physicians 
located in and around research centers as most likely to continue curative treatment beyond 
benefit to the patient.  Hospice leaders perceive physicians as too busy to manage dying patients 
well and unlikely to refer because it is not in their financial best interest.42   
 
Though use of hospice in Maine is low compared to the nation, Maine does have a relatively 
high proportion of primary care physicians and primary care subspecialty physicians certified in 
palliative medicine: 0.78% of Maine primary care physicians have this certification compared to 
the national average of 0.33%.6   
 
Physician Knowledge and Comfort in Addressing End-of-Life Issues 
Physicians and residents may have little knowledge of or exposure to end-of-life issues and little 
comfort addressing these concerns with patients and caregivers.  Though all internal medicine 
physicians within a staff-model HMO regarded hospice as providing high-quality end-of-life 
care, very few (16%) correctly identified the National Hospice Organization’s eight diagnoses 
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considered appropriate for hospice referral and fewer (12%) were aware of that organization’s 
guidelines for determining prognosis in non-cancer diseases.36  In examining the ability of 
medical residents to discuss end-of-life care with patients, very few residents met expert 
recommendations for the content of advance directive discussions with patients or had received 
useful feedback from residents or attendings about their ability to discuss end-of-life issues.43  
Physicians expressed hesitancy in confronting patients with the terminal nature of their disease, 
fearing they may signal a loss of hope to these patients by initiating the discussion.13,44,45  
Physicians may also struggle to accept palliative care when they are trained to find a cure.46  
Physicians also expressed concern that patients would interpret hospice referral as a cost-
containing measure.36   
 
Patient Preferences 
Overall patient preferences for life-sustaining treatment are a barrier to hospice enrollment.  In a 
prospective cohort study, few patients had treatment preferences that would make them eligible 
for hospice; even among those patients who had preferences consistent with hospice, few 
enrolled.47  Other sources indicate that availability of new treatment options may be an important 
factor in patients’ decisions to continue with curative care29 or to focus on curative care until 
very shortly before death, contributing to shorter hospice stays.32  Even when patients with end-
stage cancer were fully informed of hospice alternatives, the majority elected to continue 
interventional treatment.48  On the positive side, however, patient and family preferences for 
quality end-of-life care are consistent with hospice philosophy including goals of pain and 
symptom management, achieving a sense of completion, maintaining strong relationships with 
health care professionals, and attention to spirituality.49 
 
Refusal to Acknowledge Terminal Condition 
Refusal or failure to acknowledge the patients’ terminal condition by the patient or caregiver 
may also impede hospice enrollment.  Patients anticipating their own death appear more inclined 
to use hospice than those who hope for a cure or improvement.  Among two groups of terminally 
ill patients, 36% of non-hospice patients believed there was a chance of cure or improvement 
compared to 16% of hospice patients.50  In a region of South Carolina, physicians felt that 
reluctance on the part of the patient and family to admit that death was imminent resulted in late 
referrals to hospice.51  Among physicians in a small Midwestern city who referred to hospice 
care in the community, nearly 70% reported patients and families were unwilling to accept a 
hospice referral.  Over half of physicians reported that families did not want strangers in their 
home.40  
 
Misunderstandings about Benefit 
Misconceptions about hospice care and lack of knowledge of end-of-life care also act as barriers.  
In interviews with caregivers at one hospice agency, caregivers had difficulty describing hospice 
during study interviews and were particularly unaware that providing comfort is a main focus of 
hospice care.  Over half of caregivers perceived hospice as a last resort service and one-quarter 
saw hospice as a service for cancer patients only.13  Outpatients in Oregon lacked knowledge of 
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Cultural or Social Issues Effecting Hospice Use 
Cultural or social issues limiting hospice use include the lack of awareness of hospice services 
and lack of culturally and linguistically appropriate services.  In focus groups with African-
Americans and Hispanics, the primary barrier to hospice use was an overwhelming lack of 
awareness of hospice among participants.  Additionally, African-Americans reported mistrust of 
the quality of care they might receive.53  Focus group discussions in California revealed that 
hospices may discriminate against patients because of staff fears and prejudices (e.g., visiting 
poor neighborhoods) and that they often lack resources to provide culturally-appropriate care.  
Some communities and families view planning for death in advance as inappropriate or 
undesirable.37 
 
Despite these barriers, African-Americans and Hispanics focus group participants described 
strong preferences for end-of-life care that involved family members and provided for the well-
being of the patient and family, preferences that are consistent with hospice care.53 
 
Eligibility Requirements 
Hospice is typically available for patients with a terminal illness whose physician believes they 
have six or fewer months to live.  Implementation or interpretation of eligibility may vary in 
practice, with some hospice agencies restricting enrollment based on patient characteristics or 
patient use of medical or palliative interventions.  Among California hospice programs in 1999-
2000, a significant proportion mandated that patients meet several requirements prior to 
enrollment.  These requirements included: patient must have a willing caregiver in the home 
(26%); patient must be willing to forgo future hospital admissions (29%); patient cannot be 
receiving total parenteral nutrition (38%); and patient cannot be receiving radiotherapy (36%), 
chemotherapy (48%), and transfusions (25%).  Larger hospices and hospice programs part of a 
chain were consistently less likely to limit admission.54  From a national perspective, interviews 
with hospice experts revealed concern that Medicare beneficiaries without a caregiver or who 
have a frail caregiver may be denied hospice access.  These experts also reported that hospices 
may restrict access to beneficiaries using curative interventions (such as chemotherapy, radiation 
therapy, or surgery) that may also provide palliation because these interventions are not covered 
under the Medicare hospice benefit and represent an additional cost to the hospice.29  
 
As part of a Medicare fraud and abuse investigation, the OIG examined compliance with the six-
month eligibility rule for Medicare beneficiaries receiving hospice services in 1995 and 1996.  
Advocates and the hospice industry expressed concern that this scrutiny would slow hospice 
entry for patients with non-cancer diagnoses, because of the difficulty in determining life 
expectancy for these patients.32  In response, Congress modified the six month rule in 1997 to 
permit physicians to recertify patients who did not die within six months.  Since then, 
beneficiaries have been eligible for an unlimited number of 60 day extensions as long as their 
physician continues to certify the patient as terminal.  However, this has not resulted in any 
effect on hospice length of stay.27  
 
Payment Structure in Nursing Homes  
A potential barrier to receiving hospice care in a nursing home includes the payment structure of 
room and board costs for patients dually-eligible for Medicare and Medicaid.  Room and board 
costs for hospice care are not covered by Medicare; however, state Medicaid programs cover 
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these costs for dual-eligibles in a nursing home.11  Hospices are paid by state Medicaid programs 
and must, in turn, pay nursing facilities for room and board for these patients.  The state nursing 
facility payment is reduced by 5% when a beneficiary enrolls in hospice.  The hospice then 
negotiates a room and board rate with the nursing facility.  This has been perceived as 
controversial because of the potential for kickbacks.55  Other barriers include the need for 
training of nursing home staff in caring for the terminally ill and better specification of the 
distinction between responsibilities of nursing home and hospice staff.55 
 
Payment Rates: Financial Vulnerability of Rural Hospices 
Many rural hospices serve a low volume of patients, leaving them vulnerable to financial 
instability when faced with high cost patients.  Defining low volume as average daily census of 
three patients or less, 28% of rural nonadjacent hospices were low volume, compared to 15% of 
rural adjacent hospices, and 5% of urban hospices.26  Summed across patients, the overall 
median daily payment by Medicare to hospices in 1999 was $1,421 per day; however, low-
volume hospices had Medicare reimbursement of only $163 per day.26  In case studies of rural 
hospices, Medicare and insurance reimbursements were insufficient to cover costs, with rural 
hospices requiring fundraising and donations to cover operating expenses.  Smaller hospices may 
not provide high-cost treatments such as palliative radiation or chemotherapy because they have 
an insufficient volume of patients over which to spread these costs.28  Several studies have 
questioned whether Medicare’s reimbursement structure adequately addresses the needs of small, 
rural hospices.28,26,56 
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5BIV. Interface between Hospice Providers and Nursing Homes 
  
Benefits and Use  
The provision of hospice care in nursing homes is a growing phenomenon that offers both 
challenges and opportunities. When enrolled in hospice, a nursing home resident and their 
families receive physical, psychosocial, and spiritual support and care from a hospice team, 
including drug coverage for medications related to their terminal illness. Residents who receive 
Medicare Part A skilled nursing facility care cannot access Medicare hospice.  
 
It is estimated that approximately one quarter of all deaths occur in nursing facilities with 
mortality rates as high as 34% during the year after a nursing home admission. Similarly, 
residential care and assisted living facilities increasingly provide end-of-life care, with one study 
documenting mortality rates between 16% and 22%.20 
 
Between 1991 and 2000, the number in inpatient facilities providing hospice care increased by 
more than nine times and the majority of these patients resided in nursing homes rather than 
hospitals or other facilities.  Many hospice patients received nursing home care before they 
began receiving hospice care in the same facility.35   
 
 
End-of-Life Care in Nursing Homes 
Studies of end-of-life care in nursing homes suggest that nursing home residents do not receive 
optimal palliative care. In one study, almost one quarter of residents with daily cancer pain 
received no pain medication and residents were often transferred to hospitals for aggressive care 
in the last weeks of life.57  Families have also expressed dissatisfaction with end of life care in 
nursing facilities.21  
 
Quality of Hospice Care in Nursing Homes 
Hospice use in nursing facilities has been associated with indicators of quality care, including 
enhanced personal care and pain and symptom management,20 reduced hospitalizations,19 and 
was well-valued by family members.58  
 
Satisfaction of family members of nursing home residents who use hospice and those who did 
not have found mixed results.  One study conducted in a sample of residential care and nursing 
facilities in four states found high levels of family satisfaction of both groups.  The study found 
no differences in care and outcomes between decedents who did and did not receive hospice, 
with the exception of treatment of pain.20  Another study found that those nursing facility 
residents who enrolled in hospice had fewer acute care admissions, spent fewer days in acute 
care, and families rated the resident’s care more highly than did families of residents who did not 
receive hospice.59  
 
Variation in Use of Hospice in Nursing Homes 
The rate of hospice use in nursing homes varies considerably across the country. The percent of 
nursing homes with at least one person receiving Medicare hospice in 2001 ranged from 37% in 
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Wyoming to 96% in Florida. Maine ranked 49th with 41% of nursing homes collaborating with a 
hospice.60  
 
A number of factors contribute to the differences in use of hospices in nursing facilities. States 
with higher levels of collaboration tended to have larger hospices. In addition, states with a 
higher percent of older adults in rural areas and states with higher nursing home occupancy rates 
had lower rates of hospice collaboration.  The presence of Medicaid case mix payment was also 
associated with lower levels of nursing home/hospice collaboration but since state case mix 
payment systems differ significantly, the association is not entirely clear.  Some states with 
Medicaid case mix reimbursement began removing residents enrolled in hospice from a nursing 
home’s calculated case mix rate creating a chilling effect on hospice/nursing home 
collaboration.60  
 
Organizational and Policy Factors 
Other organizational and policy factors contribute to the rate of nursing home and hospice 
collaboration. Some nursing home administrators are hesitant to collaborate because they fear 
surveyor citation when care approaches are different than what regulations encourage (e.g., 
honoring a person’s wish not to eat or drink).  Initiation of hospice can be administratively 
burdensome. Policies and procedures must be established to achieve well coordinated billing, to 
integrate care and care planning across programs and staff, and ensure consistent communication 
at all levels.  Hospices providing large amounts of care in nursing homes have special teams for 
nursing home residents and manuals and forms specific to coordinating care.60 
 
The complexities of payment particularly for residents who are dually eligible for Medicaid and 
Medicare can be a barrier. In some states, the nursing home Medicaid per diem is paid directly to 
the hospice who in turn pays the nursing home. In other states, Medicaid pays a per diem rate 
directly to the nursing home. This often results in delays in payments. It is often not clear what 
constitutes a duplication of services when hospice is provided in a nursing home.   
 
Professional Factors 
Another major challenge is the difficulty of two organizations and two specialties working 
together to provide end-of-life care.  Barriers related to interprofessional and interorganizational 
collaboration impede such collaboration. Nurses, aides, social workers, clergy and physicians 
employed in nursing homes and hospice have training and experience in environments with 
different care philosophies, approaches and goals of care.61  Barriers related to nonprofessional 
collaboration include distrust of other occupational groups and lack of respect and trust of other 
approaches to care.  Other challenges include role competition, role confusion, and turf issues.61  
 
Successful Collaboration 
A study of 19 nursing home/hospice collaborations examined the barriers as well as the practices 
that resulted in successful collaboration. Interviews were held with 19 nursing homes and 
hospice providers.  Of those studied, all hospices initiated the collaboration although their 
reasons for initiating the collaboration varied. Some felt that their mission required them to offer 
hospice in any nursing home while others more selectively worked with nursing homes with 
quality reputations.  Nursing homes on the other hand often limited the number of hospice 
contacts to reduce the number of contacts with which the staff had to contend.    
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Most of the nursing home staff reported receiving hospice training on Medicare admission 
criteria.  The most common reasons for referring to hospice were presence of poorly managed 
pain and family problems with impending death. Physicians rarely initiated hospice referral; 
referral most often occurred after hospice was suggested by the social worker. Nursing home 
nurses and social workers appeared to be the gatekeepers of hospice referral.  Families often 
requested hospice after seeing the additional services provided to another patient in the facility 
who received hospice care.  Care planning between the nursing home and hospice was not 
typically integrated into one plan; nursing homes reported that they included the hospice in their 
care plan but the hospices usually had separate care plans.61   
 
Differences in the philosophies regarding approach to care tended to diminish the longer a 
hospice was partnering with a nursing facility.  When interviewed, the nursing home staff 
identified a number of benefits from the provision of hospice in the facility including extra one-
on-one care and psychosocial support to residents and families.  It was also important to the 
nursing home staff that their knowledge and skills be recognized. The presence of hospice 
influenced the care within the home particularly related to pain and symptom management, staff 
attitudes toward death and dying, and focus on comfort care.61  
In instances of successful hospice/nursing home collaboration, nursing home staff and 
administrators reported that hospice helps to provide more one-on-one care to dying residents 
and there was a “spill-over” effect when there was greater hospice presence in the nursing home. 
Such homes are likely to have fewer hospitalizations at end-of-life and more frequent 
assessments of pain.60 
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6BV. Care of People with Dementia at End-of-Life  
 
Alzheimer’s disease is the fifth leading cause of death among older Americans, and the mortality 
rate due to Alzheimer’s is increasing faster than any other fatal condition. Approximately 70% of 
older adults with dementia die in nursing homes, compared with 21% dying with cancer and 28% 
with other chronic diseases.  Furthermore, the percent of hospice recipients with dementia 
exceeds that in the community.  The difficulty of prognosing death for people with dementia has 
hindered access and appropriate timing of referrals for dementia patients.  Studies of the end-of-
life experience of people with dementia have been limited.  
 
For this reason, a more recent study examined families’ end-of-life experience for those with 
dementia compared with decedents with other common terminal illnesses.  Using a national 
sample of the Family Evaluation of Hospice Care Survey, the study examined family members’ 
experience with hospice care.  In general, all respondents rated hospice care as excellent, 
regardless of diagnosis.  Seventy-six percent of respondents rated their satisfaction as excellent 
compared with 73% of families whose loved one had dementia. In all groups, approximately 
17% of respondents reported at least one problem with coordination of care; 20% reported at 
least one problem with the patient’s overall condition; and 30% with the provision of emotional 
support to the family.  The responses from family members of decedents with dementia versus 
cancer or other chronic disease were similar across groups.16  
 
The difficulty of accurately estimating life expectancy of people with dementia has been cited as 
a barrier to timely and appropriate access to hospice care.  The Medicare hospice benefit requires 
that beneficiaries have an estimated life expectancy of less than six months.  National surveys of 
hospice providers have cited the difficulty of predicting survival as a major problem in the 
delivery of care to people with dementia. A recent study used MDS data from nursing homes to 
develop a risk score for predicting six month survival.  The results of the study indicate that 12 
variables from the MDS estimate six month mortality for nursing home residents with advanced 
dementia with greater accuracy than existing prognostic guidelines.62  
 
A recent report from the Alzheimer’s Association identifies the important aspects of end-of-life 
care for people with dementia in residential care settings.  The most important issues included 
communication and decision making about end-of-life care.  Experts agreed that health care 
professionals (doctors, nurses, social workers) must be prepared to discuss resident’s care goals 
and progressive and inevitable decline toward death that is expected with dementia.  This 
includes “planting the seed” for discussion about goals for the resident as early as possible.  
 
Symptom management, particularly because of residents’ aphasia, was noted as a particular 
challenge.  Psycho-social and spiritual support for residents and family members is also 
important.  A key component of this support is the interaction with the facility staff and the 
resident.  Providers also play a key role in supporting family caregivers throughout the long 
grieving process and in providing bereavement support after the death of a resident. The major 
public policy barriers to delivering quality palliative care in nursing homes included: the 
incompatibility of the Medicare skilled nursing facility benefit and the hospice benefit; Medicare 
hospice eligibility criteria; differences in quality assurance systems, and inadequate provider 
reimbursement.63  
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7BVI. Payment Issues  
 
The Medicare hospice benefit covers an array of services including skilled nursing services, 
drugs, physical, occupational and speech therapy, counseling, home health aids and homemaker 
services, short-term inpatient care, short-term respite care and other services necessary for 
palliation and management. Payments for hospice are made according to a fee schedule that has 
four basic components: routine care, continuous home care, inpatient respite care, and general 
inpatient care. The payments vary by location and intensity of services provided and are adjusted 
for differences in area wage rates.64  In addition to these rates, there are two fixed annual caps; 
one is a dollar amount and the other limits the number of days of inpatient care. The caps are 
based on an agency level rather than on a patient specific level.5  
 
MedPAC has recommended an evaluation of the hospice payment structure to ensure rates are 
consistent with costs of providing adequate care. Specific recommendations were made to 
examine adjustments for patient case mix, outliers, length of hospice enrollment, setting (home 
or nursing home), geographic region (urban or rural) and eligibility requirements.5  
 
Changes in the mix of patients served by the Medicare hospice program, the settings in which 
people are receiving services, and changes in palliative treatments raised questions about 
whether the Medicare hospice payment system accounts for the current costs of caring for 
hospice users. Limitations on data for cost and use of hospice by Medicare beneficiaries in 
nursing homes have impeded full analysis of these questions. Historically, Medicare hospice data 
did not readily allow identification of nursing home residents and did not include beneficiary 
level data on the number and types of visits, use of drugs, equipment and supplies, etc. MedPAC 
and others continue to examine the adequacy of the payment rates and the need to re-examine 
their structure given the changes in the use patterns of hospice beneficiaries since the time the 
original program and payment system was designed.  
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8BVII. Cost Effectiveness 
 
Studies on the high cost of health care in the last year of life have focused attention on the cost 
effectiveness of hospice programs.  Previous studies have shown that spending in the last year of 
life is almost six times higher, on average, than the annual spending of  Medicare beneficiaries 
who do not die.5  One study of expenditures in Massachusetts and California found that Medicare 
expenditures in the last year of life decrease with age, especially for those 85 years of age and 
older. This is in large part because the aggressiveness of medical care in the last year of life 
decreases with increasing age.65  
 
Many studies have examined whether the use of hospice services saves money for the Medicare 
program. In fact, the hospice benefit was originally designed (with restrictive eligibility criteria, 
waiver of curative care and the cost caps) to reassure policymakers that it would not substantially 
increase Medicare costs.5  Early results from the National Hospice Study found that home-based 
hospice and hospital-based hospice patients cost less than those without hospice, particularly in 
the last months of life and overall in the last year of life.66  
 
The change in enrollment patterns and the mix of patients served in hospice (e.g. an increase in 
non-cancer patients such as patients with COPD, congestive heart failure and Alzheimer’s 
disease) have provided impetus for continued study of this question.  
 
More recent studies have shown mixed results. A study using a 5% sample of all Medicare 
beneficiaries in 1999 and 2000 examined the costs of 16 narrowly defined types of diagnoses 
including a number of cancers, COPD, Alzheimer’s disease and stroke. The study examined the 
cost until death for patients choosing or not choosing hospice, starting with the date of a 
predefined “indicative marker.”  The indicative marker was used to indicate the point at which a 
patient would shortly thereafter be advised to consider obtaining hospice. For all diseases except 
prostate cancer and stroke, mean cost was lower for patients who chose hospice, but this was 
significant only for CHF, liver cancer and pancreatic cancer. The study also showed that certain 
patients who chose hospice lived longer than those who did not.67   
 
Another study published the same year, however, found that Medicare costs in the last year of 
life were higher overall among hospice enrollees than non-enrollees, although this varied 
according to diagnosis. The study found that hospice use appeared to reduce Medicare 
expenditures for those with cancer who are younger than 85 years of age but to increase costs for 
patients without cancer and all patients over 85 years of age.  Overall, hospice users were found 
to incur costs that were 4% greater than similar patients who did not use hospice, with the 
relative costs of hospice highest among patients with dementia and relatively nonspecific 
diagnoses.  The authors suggest that these patterns reflect differences in service needs and in 
trajectories to decline and death. Cancer, for example, is associated with a short period of decline 
at end-of-life; diseases associated with organ system failure, such as heart and lung disease, tend 
to be associated with long-term limitations with intermittent serious episodes; and deficits in 
self-care associated with frailty or dementia have prolonged and dwindling declines.68  One key 
factor explaining this result was that hospice decedents without cancer tend to use more intense 
hospital inpatient services before they enter hospice and have more expensive hospice stays.  
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A more recent study used an approach intended to account for weaknesses in earlier studies, 
namely the period of time over which costs of hospice users and nonusers are compared. 
Previous studies have used the last year of life as the focal point for such comparisons. Because 
of the extreme variation in the length of hospice use, determining the appropriate time over 
which to estimate cost savings is difficult. This study used an approach that identified the length 
of hospice use associated with the maximum expenditure reductions possible.  This was done 
using a retrospective case control method that identified hospice users and then created a control 
group of similar people who did not use hospice.  Hospice use reduced Medicare expenditures by 
around of $2,300 per hospice user; expenditures after initiation of hospice were $7,318 for 
hospice users compared with $9,627 for controls. Total costs for the entire last year of life did 
not differ between hospice users ($32,727) and controls ($33,837).  However total Medicare 
costs during the last year of life prior to hospice entry were higher for hospice users compared to 
controls. Most of this cost difference occurred in the week prior to initiation of hospice.69   
 
All of the above studies and indeed most of the literature focus on cost savings attributable to the 
Medicare hospice benefit. An actuarial analysis conducted by Milliman for the National Hospice 
and Palliative Care Organization in 2003 examined the question of the value of the hospice to the 
Medicaid program. This study focused primarily on the Medicaid only hospice program although 
it also looked at the impact of Medicare hospice on Medicaid patients in nursing homes.  This 
study estimated that without hospice, Medicaid would pay an additional $228 million in order to 
continue end-of-life care in the hospital; an additional $41 million to pay for expensive 
pharmaceutical treatments; and an additional $13 million for the payment to nursing homes, due 
to the technical way in which nursing homes are paid when a person who is dually-eligible for 
Medicaid and Medicare receives Medicare hospice in the nursing facility.2  
 
We found no studies of the substitution effect and potential cost savings associated with the use 
of the Medicare hospice benefit by Medicaid participants.  For Medicaid patients who are 
receiving care at home or in a long term care facility, the use of the Medicare hospice benefit 
could potentially result in reductions in Medicaid costs associated with home care services, and 
residential care and nursing facility services.  This is an area worthy of further study and could 
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9BVIII. Opportunities for Improving Access  
  
The barriers to the timely use of hospice discussed above still leave open the question of how to 
improve access and early use of the services available. Those who have studied this question 
suggest that it is time to look at the use of hospice through the view of the user and consider the 
factors that improve the usability of the program. Casarett proposes the use of the usability 
paradigm to better understand ways to improve the system. According to this approach, it is 
helpful to review the definition of “usability.”57  
 
Usability is “that quality of a system that make it easy to learn, easy to use and encourages the 
user to regard the system as a positive help in getting the job done.” Under this theory, one can 
either make the product more usable (e.g., the design of the benefit, structure of payments) or 
improve the user interface. Casarett argues that it is important to view the program from the 
perspective of the user. The key elements to consider as part of the user interface are 1) who 
initiates the hospice decision 2) the timing of the decision 3) who makes the decision and 4) the 
information that patients and family members need to know and when they need or want to know 
it.57  
 
Decision Making Process for Entering Hospice 
Physicians and families are important contributors to the decision to enter hospice care though 
their actual rank of importance in decision making is unclear.  One study found that families 
made the decision to enter hospice for 42% of patients, while 28% of patients made their own 
decision, and 27% of physicians made the decision.50  Another found that physicians initiated 
76% of hospice referrals, with patients and family jointly initiating 10%.70  However, there may 
be greater reliance on physicians for end-of-life issues in Maine.  Speaking hypothetically about 
their own needs for end-of-life care, nearly all (98%) of Maine adults would discuss these issues 
with a physician.  Only 35% said they would discuss their needs with a family member.41 
 
Preparing for Hospice Care 
The literature reveals specific information needs for terminally-ill patients and ways to identify 
patients potentially eligible for hospice.  Patients and families deciding whether to enroll in 
hospice have specific information needs including the frequency of hospice visits, the type of 
practical support hospice provides at home, and payment options.  Efforts to enroll patients 
earlier in hospice should focus on providing these pieces of information to patients and family.14  
An intervention in nursing homes composed of a brief scripted interview and simple criteria to 
determine hospice appropriateness resulted in hospice referral for approximately 20% of nursing 
home residents within 30 days.  The interview identified residents whose goals for care, 
treatment preferences, and palliative care needs made them appropriate for hospice care.  The 
authors suggest this intervention could be implemented in any long-term care setting and used 
with minimal staff training.59 
 
Hospice use appears to be predicted among persons well-prepared for end-of-life issues in 
general.  In Utah, hospice use was associated with having a living will, knowledge that illness 
would lead to death, and information about what to expect at the time of death and after death.18  
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Earlier referrals and longer hospice length of stay are associated with greater perceived benefits 
among caregivers.  Longer hospice enrollment before death was associated with higher family 
ratings of residents’ quality of care59,71 as well as greater relief of caregiver burden13 and 
caregiver mental health.72  Optimal length of stay is difficult to identify but studies suggest that 
most benefits are provided when patients stay between three weeks and three months 14 or as 
soon as active treatment is discontinued.13   
 
Coordination and Transition Support 
The literature reveals provider models using elements of curative and palliative care that have 
successfully demonstrated continuous care and increased hospice referral.  These include home-
based programs that ease the transition between curative and hospice care 73, 74 and concurrent 
care by cancer and hospice providers.75  Many commercial plans do not require the suspension of 
curative treatment while a patient undergoes hospice. Two large insurers – Aetna and Kaiser 
Permanente have started programs that allow patients with terminal illnesses to receive a 
combination of palliative and curative care5,  approaches that combine life-prolonging treatment, 
palliation of symptoms, and support for caregivers may potentially be a more effective form of 
end-of-life care and remove barriers to hospice access.35  Some suggest that one way to move 
palliative care “upstream” is to introduce a care manager to the process early on. The care 
manager would walk the patient and family through the disease process from diagnosis to 
bereavement.76  A number of the programs that have been developed to offer more 
comprehensive and coordinated programs for end-of-life care have done so through the use of 
capitated payments that provide greater flexibility to providers in developing and managing care 
and services.  
 
Medicaring 
Many researchers have called for Medicare to encourage the provision of palliative care that is 
not so tightly tied to prognosis.5  One model of care that is being discussed for end of life care is 
called Medicaring. The core idea is to have eligibility criteria more appropriately align with the 
three major trajectories of decline.  The criteria would be “replicable and administratively 
feasible” rather than accurate.  Supporters suggest that this approach provides an opportunity to 
blend the interdisciplinary team, continuity and symptom relief that are part of hospice with the 
self education, timely reminders for prevention and advance care planning associated with 
successful chronic illness management.  The ideal funding for such an idea is a capitated rate that 
blends Medicaid and Medicare payment.54  
 
Advanced Illness Management Program 
Another example of a program that seeks to support the continuity of care for people with 
advanced but not necessarily terminally ill patients is the Advanced Illness Management 
Program. A program of a VNA and hospice provider, the program provides a full range of 
services for people at home with a serious illness that are nearing the end-of-life. This program 
offers a combination of home care, which can be episodic, and palliative care for people who 
have not yet chosen hospice.  The program provides concurrent disease modifying and comfort 
care. An evaluation of the program found a 28% difference in the number of hospice referrals 
between patients who received the AIM intervention and those who did not.  The program was 
considered successful at increasing hospice utilization through a targeted intervention focused on 
palliative and end-of-life care, increased patient education, and a dynamic treatment approach.73  
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10BIX. Opportunities for Improving Quality  
 
New initiatives are underway to bring quality assessment and improvement activities to the 
hospice industry.  The National Hospice and Palliative Care Organization (NHPCO) developed 
standards of care for hospice programs in 1979; however, there has been no enforcement of those 
standards or way to determine compliance.  Since 2000, the NHPCO has sponsored a National 
Data Set to establish benchmarks for hospice practice throughout the country.3  Participation in 
the NDS allows hospices to compare themselves against other hospice providers performing 
similar activities.  A 2006 report by the National Quality Forum endorses a framework for 
developing a comprehensive quality measurement and reporting system for palliative care and 
hospice services and endorses a set of preferred practices designed to improve palliative and 
hospice care.4  The Medicare Payment Advisory Commission has recommended that Medicare 
should establish and collect quality measures for public reporting to encourage hospice quality 
improvement.5    
 
A Robert Wood Johnson Foundation Initiative funded a Toolkit of Instruments to Measure End-
of-Life Care (TIME).  A goal of this program is to incorporate perspectives of patients and 
family members that are clinically meaningful and are reliable and valid.17  
 
The minimum data set for nursing facilities (MDS) has core information that provides a starting 
point for developing some quality measures for end-of-life care. These include indicators such 
as: use of advance directives in terminally ill patients; do-not-resuscitate orders among nursing 
facility residents with severe cognitive impairment; use of feeding tubes among people with 
severe dementia; and use of hospice by nursing facility residents.  Similar measures could be 
developed from the MDS-RCA (for people in residential care facilities) and people using home 
care.   
 
Two organizations provide accreditation services to hospice agencies.  Since 1984, the Joint 
Commission (formerly the Joint Commission for Accrediting Health Organizations) has offered 
accreditation of home-based hospice programs.  It does not appear that the Joint Commission 
offers accreditation for hospice provided in other settings.  Since 1999, the Community Health 
Accreditation Program, Inc. has been the regulatory authority to survey agencies providing 
hospice services, to determine whether they may provide services to Medicare beneficiaries. 
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11BX. Research Questions for Maine 
 
The results of this literature review suggest a number of further questions for research. These 
include:  
• What is the rate of hospice use by setting (e.g., home, hospital, nursing home, patient 
home, and residential care) in Maine? How does this compare with national use rates? 
Who is using those services (e.g. people with dementia, people with cancer, etc) 
• What is the relationship between supply of hospice providers and other providers and use 
of hospice in Maine? How does this vary by urban/rural areas? 
• What percent of people in long term care in Maine have diagnoses and ADL levels that 
are potentially consistent with hospice use?  Are people who might be eligible for hospice 
being informed of/offered/using hospice? 
• What are the factors that promote successful use of hospice in residential care and 
nursing facilities?  
• What is the quality of hospice services provided in Maine? 
• What is the impact of Medicare hospice use on Medicaid costs?  
• Are there ways to improve the coordination of end-of-life care and financing between 
Medicaid and Medicare?  




Data is critical to understanding the cost, use and quality of hospice services in Maine. There are 
a number of data sources available that can help better inform policy and practice in Maine. This 
includes Medicare and Medicaid data, MDS nursing home data, MDS-RCA residential care data, 
and Mecare home care data. In addition, the hospice providers have data that is unique and could 
further inform policy and practice, These includes data on supply, use of services by type of 
providers, and quality of services. Data, as transformed into information, is necessary to fully 
inform research, policy and practice on an ongoing basis.   
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